Jose-Maria Abellan-Perpiñan

Prof. Dr. Jose-Maria Abellan-Perpiñan

Department of Applied Economics, Faculty of Economics and Business, University of Murcia, 5 - 30100 Murcia, Spain
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2011 in Health Economics
Verified
Journal Article
Closed access
PDF file
JAJose-Maria Abellan-Perpiñan
Jose-Maria Abellan-Perpiñan
FSFernando-Ignacio Sánchez
Fernando-Ignacio Sánchez
JPJorge Eduardo Martínez Pérez
Jorge Eduardo Martínez Pérez
IMIldefonso Méndez
Ildefonso Méndez

16 March 2012 in Social Choice and Welfare
Verified
Journal Article
Closed access
PDF file
JPJose-Luis Pinto-Prades
Jose-Luis Pinto-Prades
JAJose-Maria Abellan-Perpiñan
Jose-Maria Abellan-Perpiñan

5 April 2024 in International Journal of Technology Assessment in Health Care
Verified
Journal Article
Open access
PDF file
FSFernando-Ignacio Sánchez
Fernando-Ignacio Sánchez
JAJose-Maria Abellan-Perpiñan
Jose-Maria Abellan-Perpiñan
JMJorge-Eduardo Martínez-Pérez
Jorge-Eduardo Martínez-Pérez
JGJorge-Luis Gómez-Torres
Jorge-Luis Gómez-Torres
Objectives: This study aims to develop a framework for establishing priorities in the regional health service of Murcia, Spain, to facilitate the creation of a comprehensive multiple criteria decision analysis (MCDA) framework. This framework will aid in decision-making processes related to the assessment, reimbursement, and utilization of high-impact health technologies. Method: Based on the results of a review of existing frameworks for MCDA of health technologies, a set of criteria was proposed to be used in the context of evaluating high-impact health technologies. Key stakeholders within regional healthcare services, including clinical leaders and management personnel, participated in a focus group (n = 11) to discuss the proposed criteria and select the final fifteen. To elicit the weights of the criteria, two surveys were administered, one to a small sample of healthcare professionals (n = 35) and another to a larger representative sample of the general population (n = 494). Results: The responses obtained from health professionals in the weighting procedure exhibited greater consistency compared to those provided by the general public. The criteria more highly weighted were “Need for intervention” and “Intervention outcomes.” The weights finally assigned to each item in the multicriteria framework were derived as the equal-weighted sum of the mean weights from the two samples. Conclusions: A multi-attribute function capable of generating a composite measure (multicriteria) to assess the value of high-impact health interventions has been developed. Furthermore, it is recommended to pilot this procedure in a specific decision context to evaluate the efficacy, feasibility, usefulness, and reliability of the proposed tool.

22 September 2021 in Journal of Risk and Uncertainty
Verified
Journal Article
Open access
PDF file
FSFernando-Ignacio Sánchez
Fernando-Ignacio Sánchez
JMJorge-Eduardo Martínez-Pérez
Jorge-Eduardo Martínez-Pérez
JAJose-Maria Abellan-Perpiñan
Jose-Maria Abellan-Perpiñan
JPJosé-Luis Pinto-Prades
José-Luis Pinto-Prades
This study estimates the value of statistical life (VSL) on a road traffic accident using the Contingent Valuation/Standard Gamble chained approach. A large representative sample (n = 2020) is used to calculate a VSL for use in the evaluation of road safety programmes in Spain. The paper also makes some methodological contributions, by providing new evidence about the consistency of the chained method. Our main results are: (1) A range from 1.3 million euro to 1.7 million euro is obtained for the VSL in Spain in the context of road accidents. This range is in line with the values used in the same context in other European countries, although it is lower than those obtained in different contexts and with other methods. (2) The method performs much better in terms of scope sensitivity than the traditional contingent valuation method, which asks subjects about their willingness to pay for very small reductions in the risk of death. (3) We introduce a new ‘indirect’ chaining approach which reduces (but does not remove) the disparity between direct and indirect chaining approaches. More extreme VSL estimates are still obtained with this indirect method than with the direct one. (4) VSL estimates depend on the injury used. More specifically, we obtained a lower VSL when a more severe injury is used. (5) Framing the risk of death in the modified standard gamble question as “10nin 10,000” instead of “nin 1000” influences the value of VSL. We attribute this effect to the Ratio Bias.

1 March 2016 in Social Science & Medicine
Verified
Journal Article
Closed access
ERE. Rodríguez-Míguez
E. Rodríguez-Míguez
JAJose-Maria Abellan-Perpiñan
Jose-Maria Abellan-Perpiñan
XAX.C. Alvarez
X.C. Alvarez
XGX.M. González
X.M. González
ASA.R. Sampayo
A.R. Sampayo

1 February 2009 in Revista Espanola de Salud Publica
Verified
Journal Article
Closed access
PDF file
JAJose-Maria Abellan-Perpiñan
Jose-Maria Abellan-Perpiñan
FMFernando Ignacio Sánchez Martínez
Fernando Ignacio Sánchez Martínez
JPJorge Eduardo Martínez Pérez
Jorge Eduardo Martínez Pérez
The aim of this paper is to promote the efficiency in the process of incorporating new health technologies, as well as to guide their implementation by physicians. An iterative method has been used to draw a checklist based on parsimony and measurability criteria. Authors made a first version of the checklist on the basis of theoretical literature and economic evaluation guidelines. This preliminary version was discussed and its validity was tested in two focus groups by doctors and managers of the regional public health systems of Murcia and Andalusia. As a result of this iterative process, we present a 12 criteria checklist in which a score is assigned to everyone of its items. The overall score a study receives (with a maximum of 100 points) is confronting to a set of cost per QALY thresholds, in order to assess if the technology been evaluated is cost-effective or not. The thresholds was selected from a previous study. We present a checklist and user guide which includes a cost per QALY thresholds matrix. This is an original proposal that has not been previously published in the Spanish literature. Our instrument needs some future improvements in terms of its validation and its spread to other types of cost-effectiveness analysis, apart from those that use QALYs. Nevertheless, our proposal may be useful to provide guidance on the usage and financing of new health technologies in Spain.